Junichiro Hirata

Treatment outcome after sequential chemotherapy with cisplatin-etoposide, amrubicin and nogitecan in patients with treatment-related pure small-cell neuroendocrine prostate cancer.

K. Harada, M. Fujisawa, J. Furukawa, 2023, Japanese journal of clinical oncology.

Prognostic model using postoperative normalization of C-reactive protein levels in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy

Riku Uematsu, Yoshie Mita, Junichiro Hirata, 2023, Canadian Urological Association Journal.